Position in JNJ
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$10,194,863
+$247,867 QoQ
Shares Held
40,142
-1.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.90%
of 13F equity value
Holder Rank
#1,099
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DELTA ASSET MANAGEMENT LLC/TN holds $27,667,664 across 14 Drug Manufacturers - General names. JNJ ranks #1 (36.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
40,142 | $10,194,863 | |
| 2 | ABBV |
AbbVie Inc.
|
30,429 | $7,657,153 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
75,264 | $4,336,711 | |
| 4 | PFE |
Pfizer Inc
|
105,462 | $2,539,524 | |
| 5 | MRK |
Merck & Co., Inc.
|
12,334 | $1,584,919 | |
| 6 | LLY |
ELI LILLY & Co
|
671 | $804,817 | |
| 7 | AMGN |
Amgen Inc
|
999 | $361,757 | |
| 8 | GSK |
GSK plc
|
2,138 | $112,073 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,194,863 | 40,142 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $9,946,996 | 40,693 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $8,660,236 | 41,847 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $7,846,232 | 42,316 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $6,632,863 | 43,423 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $7,076,226 | 42,669 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $6,243,823 | 43,174 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $7,179,582 | 44,302 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $6,652,180 | 45,513 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $7,286,231 | 46,060 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $7,424,303 | 47,367 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $7,574,745 | 48,634 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $8,037,982 | 48,562 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $7,471,620 | 48,204 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $7,549,491 | 42,737 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,964,853 | 42,635 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $7,399,504 | 41,685 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $7,524,831 | 42,458 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $7,253,710 | 42,402 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $6,732,289 | 41,686 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $6,763,730 | 41,057 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $6,247,929 | 38,016 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $5,809,367 | 36,913 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $5,358,488 | 35,992 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $5,008,678 | 35,616 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $4,538,409 | 34,610 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||